-
D286644-100mgReversibly blocks Yoda1 activity: does not affect constitutive Piezo1 activity.
-
D286644-10mgReversibly blocks Yoda1 activity: does not affect constitutive Piezo1 activity.
-
D286644-25mgReversibly blocks Yoda1 activity: does not affect constitutive Piezo1 activity.
-
D286644-50mgReversibly blocks Yoda1 activity: does not affect constitutive Piezo1 activity.
-
D286644-5mgReversibly blocks Yoda1 activity: does not affect constitutive Piezo1 activity.
-
D422708-1mlReversibly blocks Yoda1 activity: does not affect constitutive Piezo1 activity.
-
D125100-10mgBIRB 796 (Doramapimod) is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM, 330-fold greater selectivity versus JNK2, weak inhibition for c-RAF, Fyn and Lck, insignificant inhibition of ERK-1, SYK, IKK2, ZAP-70, EGFR, HER2, PKA, PKC,
-
D125100-250mgBIRB 796 (Doramapimod) is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM, 330-fold greater selectivity versus JNK2, weak inhibition for c-RAF, Fyn and Lck, insignificant inhibition of ERK-1, SYK, IKK2, ZAP-70, EGFR, HER2, PKA, PKC,
-
D125100-50mgBIRB 796 (Doramapimod) is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM, 330-fold greater selectivity versus JNK2, weak inhibition for c-RAF, Fyn and Lck, insignificant inhibition of ERK-1, SYK, IKK2, ZAP-70, EGFR, HER2, PKA, PKC,
-
-
-